454 related articles for article (PubMed ID: 7699438)
1. Indium-111-pentetreotide imaging in intra-axial brain tumors: comparison with thallium-201 SPECT and MRI.
Lee JD; Kim DI; Lee JT; Chang JW; Park CY
J Nucl Med; 1995 Apr; 36(4):537-41. PubMed ID: 7699438
[TBL] [Abstract][Full Text] [Related]
2. Comparison of gadolinium-enhanced MR and thallium-201 single photon emission computed tomography in pediatric brain tumors.
Rollins NK; Lowry PA; Shapiro KN
Pediatr Neurosurg; 1995; 22(1):8-14. PubMed ID: 7888393
[TBL] [Abstract][Full Text] [Related]
3. Whole body and tomographic scan with 111In-pentetreotide: preliminary data.
Gregianin M; Macrì C; Bui F; Varotto L; Zucchetta P
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):124-6. PubMed ID: 9002769
[TBL] [Abstract][Full Text] [Related]
4. A prospective evaluation of thallium-201 single photon emission computerized tomography for brain tumor burden.
Lorberboym M; Baram J; Feibel M; Hercbergs A; Lieberman L
Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):249-54. PubMed ID: 7721624
[TBL] [Abstract][Full Text] [Related]
5. 99Tcm-HMPAO brain SPECT in the evaluation of prognosis after surgical resection of astrocytoma. Comparison with other noninvasive imaging techniques (CT, MRI and 201Tl SPECT).
Rodrigues M; Fonseca AT; Salgado D; Vieira MR
Nucl Med Commun; 1993 Dec; 14(12):1050-60. PubMed ID: 8295760
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin receptor scintigraphy with 111In-pentetreotide in non-functioning gastroenteropancreatic neuroendocrine tumors.
Schillaci O; Spanu A; Scopinaro F; Falchi A; Corleto V; Danieli R; Marongiu P; Pisu N; Madeddu G; Delle Fave G; Madeddu G
Int J Oncol; 2003 Dec; 23(6):1687-95. PubMed ID: 14612942
[TBL] [Abstract][Full Text] [Related]
7. Dynamic indium-111-pentetreotide scintigraphy in breast cancer.
Bajc M; Ingvar C; Palmer J
J Nucl Med; 1996 Apr; 37(4):622-6. PubMed ID: 8691252
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin receptor scintigraphy in central nervous system tumors: role of blood-brain barrier permeability.
Haldemann AR; Rösler H; Barth A; Waser B; Geiger L; Godoy N; Markwalder RV; Seiler RW; Sulzer M; Reubi JC
J Nucl Med; 1995 Mar; 36(3):403-10. PubMed ID: 7884502
[TBL] [Abstract][Full Text] [Related]
9. [Imaging of pediatric brain tumors using somatostatin analogue 111Ih-DTPA-D-Phe1-octreotide].
Dabasi G; Hauser P; Kertész GP; Balázs G; Karádi Z; Constantin T; Bognár L; Klekner A; Schuler D; Garami M
Magy Onkol; 2007; 51(3):229-34. PubMed ID: 17922063
[TBL] [Abstract][Full Text] [Related]
10. SPECT improves accuracy of somatostatin receptor scintigraphy in abdominal carcinoid tumors.
Schillaci O; Scopinaro F; Angeletti S; Tavolaro R; Danieli R; Annibale B; Gualdi G; Delle Fave G
J Nucl Med; 1996 Sep; 37(9):1452-6. PubMed ID: 8790191
[TBL] [Abstract][Full Text] [Related]
11. Indium-111-pentetreotide scintigraphy in Graves' ophthalmopathy.
Kahaly G; Diaz M; Hahn K; Beyer J; Bockisch A
J Nucl Med; 1995 Apr; 36(4):550-4. PubMed ID: 7699440
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours.
Sasaki M; Kuwabara Y; Yoshida T; Nakagawa M; Fukumura T; Mihara F; Morioka T; Fukui M; Masuda K
Eur J Nucl Med; 1998 Sep; 25(9):1261-9. PubMed ID: 9724375
[TBL] [Abstract][Full Text] [Related]
13. 111In-pentetreotide scintigraphy in the detection of insulinomas: importance of SPECT imaging.
Schillaci O; Massa R; Scopinaro F
J Nucl Med; 2000 Mar; 41(3):459-62. PubMed ID: 10716319
[TBL] [Abstract][Full Text] [Related]
14. Imaging of somatostatin receptors by indium-111-pentetreotide correlates with quantitative determination of somatostatin receptor type 2 gene expression in neuroblastoma tumors.
Briganti V; Sestini R; Orlando C; Bernini G; La Cava G; Tamburini A; Raggi CC; Serio M; Maggi M
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2385-91. PubMed ID: 9815638
[TBL] [Abstract][Full Text] [Related]
15. Single photon emission computerized tomography increases the sensitivity of indium-111-pentetreotide scintigraphy in detecting abdominal carcinoids.
Schillaci O; Scopinaro F; Danieli R; Angeletti S; Tavolaro R; Annibale B; Cannas P; Marignani M; Colella AC; Delle Fave G
Anticancer Res; 1997; 17(3B):1753-6. PubMed ID: 9179229
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of 201Tl-SPECT and MRI using Gd-DTPA for glioma].
Yamada T; Maruoka S; Yamada S; Sonobe M
Nihon Igaku Hoshasen Gakkai Zasshi; 1999 Jul; 59(8):402-8. PubMed ID: 10459285
[TBL] [Abstract][Full Text] [Related]
17. Thallium-201 in brain tumors: relationship between tumor cell activity in astrocytic tumor and proliferating cell nuclear antigen.
Ishibashi M; Taguchi A; Sugita Y; Morita S; Kawamura S; Umezaki N; Shigemori M; Hayabuchi N
J Nucl Med; 1995 Dec; 36(12):2201-6. PubMed ID: 8523105
[TBL] [Abstract][Full Text] [Related]
18. Indium-111-pentetreotide uptake in endocrine tumors and lymphoma.
Leners N; Jamar F; Fiasse R; Ferrant A; Pauwels S
J Nucl Med; 1996 Jun; 37(6):916-22. PubMed ID: 8683311
[TBL] [Abstract][Full Text] [Related]
19. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
Oriuchi N; Tomiyoshi K; Inoue T; Ahmad K; Sarwar M; Tokunaga M; Suzuki H; Watanabe N; Hirano T; Horikoshi S; Shibasaki T; Tamura M; Endo K
J Nucl Med; 1996 Mar; 37(3):457-62. PubMed ID: 8772644
[TBL] [Abstract][Full Text] [Related]
20. Indium-111-pentetreotide scintigraphy in children with neuroblast-derived tumors.
Manil L; Edeline V; Lumbroso J; Lequen H; Zucker JM
J Nucl Med; 1996 Jun; 37(6):893-6. PubMed ID: 8683306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]